Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If this stock hits $30 (Nice)
But If itaros has World wide sale of $450,000 (non US) it would be very possible
Diltuing I thought the ATM agreement (or is it AMT) was discontinued
Was any of this just short covering and now the squeeeze is doen If you shorted at $3.30, $3.00 $2.90 I think you would have taken profits already. the shorted at $2.70 and under should have covered today
OK so what is happenig today Does the market like the dropping of the pill or is EU approval coming in (or rumors thereof)
Everything is for sale. The posion pill is to avoid a hostile takeover. Removing the pill means the company is for sale (IMO) at any price. Controlling interest can be had for slightly over $45 million.
The posion pill should have been removed only after EU approval and or the CN launch
Not sure why they would do this when a stock is at its low point in value. If you look at the BOD's movew this year, selling of assets, closing down marginal divisions, not investing in R&D, etc.
Were they sharpening the pencil to coserve cash (No not based on the latest PR) or are they dressing this up for a low ball offer (probably yes)
DG I did see that part of the call.
Generally there is a little buzz on a stock that has a important event coming up within 30 to days.
APRI may be teh exception
Did not have a chance to read the whole conference call transcript yet, but isn’t the waiting time likely to be close to or more than 30 days before EU news (no clock stops please). So we may be in the low volume holding pattern for May and June/
Doubtful of any CN news.
Also no new partnerships since Dr D left. Is wait and see the new strategy?
I wonder how many Next Med vets are left (Viv Lu days)
I think we know why APRI dropped from the mid 3's to the 2's lately. The Abbot CN isues leaked.
Launch by year end ???
I was actually happy to see a news item about a presentation even if they are just rehashing old old data. It has been so quiet since Dr D left (like him or not )
Based on the APRI website it will reamin be quiet until Vitaros and Femproz take off as the pipeline is been trimmed quiet a bit
I actually thought they would generate some revenue from NextACT at one time
Posted before I saw your post Binchey.
If there are any mubmlings about dilution that would explain the PPS of late.
I would be OK with a small sale to support a PIII study to validate Fprox. APRI needs the drug launched
As for those who got in APRI under $3.00 and are grumbling about being underwater, you don't know true APRI pain. Some of us have beeen around too long
That being said we all had a chance to cash in around $6 and realize gains
The PPS action is just not right. All this talk of manipulation is fine. I have some conerns
What concerns me is a another Euro clock stop or a delay in CN
Even if that happens I am OK as long as the launch goes on in CN sucessfully and APRI finally gets Euro approval
Hoepfuly there ae no plans additional funding
Forgot the manufacturing process.
Is APRI manufacturing for Abbot (I know they ordered some for WC. If yes, then won't we see another order before the launch????
Waiting for the 12 noon run up. Probably won't get oene today becaue I bought more shares yesterday
Can't work and post at the same time. Too many typos. Sorry about that.
I think the 20% recent rise from lows and the increasing volume is the sign that one or both of the long awaited catalysts are coming within a month or so. I still think we wil se Euro approval before Abbott \ CN launch
How many times has some posted that comment. but if you need to average down, now may be the time.
Interesting only the big 2 mentioned Vitaros and Femprox.
The still have a pipeline tab but that must be totally on hold until Vitaros takes off
Strange PPS Upwards move for over a week and the best move is on a market dowwn day of 100 points Now on up day the, PPS is down
How good is this?? The March $5 options are .05 and the May $5 are 12 cents
Even better the May 2.50 options are 80. This seems to good to be true I have to think the Euro issue will be settled by April
I don't have an otpion account (slef control)
Just glanced at the YMB board and saw your post So is Slugg the new Court or just a coincidence? Sorry can't see Casino posts either.
Actually I can't read most posts on the YMB board anymore due to editing.
On another note
Good to see a little volume and PPS rise.
Lets go Euro boys with the approval.
Time to hire a new chief
Lets go Abbott CN men are waiting in the wings (i hope)
Waiting to see what the French sales team can do for Equro Sales of Viaros. Maybe that model works elsewhere
Ok with me
DG, the timing of MM's disappearence and Dr. B's firing are really odd. Could be a coincidence that MM quit posting or maybe he sold. Hopefully it is that simple.
Too bad good poster
Nice to get an update. Looks like the cancer drug market is a dud. Other than Vitaros and Femrpox is everything else done, or on the back burner, such as PrevOnco, the nail fingus drug, NEXACT partnerships, etc
Abbot and AbbieVie
Abbott Laboratories (NYSE:ABT) finalizes the separation of its research-based pharmaceuticals division that is now the independent biopharmaceutical firm AbbVie (ABBV), which commences trading independently on the New York Stock Exchange on Wednesday. On November 28th, Abbott’s board of directors declared a special dividend distribution of all outstanding shares of AbbVie common stock. For every share of Abbott common shares held as of close on December 12th, Abbott shareholders received a share of AbbVie common stock on January 1st.
A little life in the PPS on a down day. Volume picking up a little. Y/E selling done??
Can't beleive they are that low They already in the money
I would prefer to wait for more Euro deals until Vitaros is approved. They should be able to deal more upfront money.
CN sales would help the cause
If Euro approval is not granted APRI is pretty much dead. Another clock stop would punish PPS
I am not to worried, they did a good job of addressing Health CN questions and issues
It is so quiet. It has been quite some time since we have had any meaningful news. No deals, no new partnerships, no preclinical tests, no updates, acquisitions. Was Dr B doing it al??
Is everything on hold until they find a new CEO or Abbott\Canada or Euro.
All or any of the above?
OK sure seems fair. I guess we keeping looking at the WC quarterly reports to ge teh answer
We are loyal to APRI and think it is a gem, our partners probably do not. They have a boat load of other revenue generating items to worry about Vitaros is just incremetnal sales. Hopefully, one year from now they will be proven wrong
WC would have moved faster on this if they thought they had a blockbuster. Abbott would be going about it in a different way also.
I do beleive that for use to see a double or a triple in PPS Vitaros doesn't have to be a blockbuster. With CN launch and Euro approval is $150 to $300 million inworld wide sales too much to ask??
Cam Femrpox generate something similar?
I am more of a half empty guy too. But I think that Abbot views Vitaros as small potatoes so they are really in a hurry to get things done.
Is APRI a buyout cadnidate - only if Euro sales are signifiant.
When is Euro approval happening? 1st half 2013?? Any chance of another clock stop
Dawson James notes
Apricus shares have declined this year for several reasons, including but not limited to: 1) An after-effect from
the March 2012 equity raise; 2) A wait-and-see approach by investors related to the financial impact of the
recent acquisitions; 3) Expectations regarding the finalization of pricing and timing of product launch of Vitaros
in Canada; and/or 4) Uncertainties regarding management transition. Interestingly enough, APRI shares are now
trading at levels below our original recommendation in late 2010, and investors can still achieve considerable
share appreciation (100%+) at our current price target of $5.50 per share.
the potential catalysts for Apricus for the remainder of 2012 and into 2013 are:
1) Soft Launch of Vitaros in Canada by Abbott (H1/2013) targeted at urologists, more comprehensive launch
later next year (H2/2013);
2) Approval in Europe for Vitaros (end of 2012 or early 2013), additional potential partnerships signed in
Europe (Spain, Eastern Europe) 2012-2013;
3) Potential response to existing US FDA Complete Response Letter for Vitaros by partner Warner Chilcott
(Nasdaq/WCRX/Not Rated) late 2012 or early 2013, potential US approval 2013;
4) Additional country filings for Vitaros in Latin America and Rest-of-World, particularly Mexico (2012-
2013);
5) Availability of Room Temperature (RT) second generation formulation of Vitaros (Duoject) 2013;
6) Regulatory guidance by health agencies in the US, Europe and Canada for Femprox (H2/2012);
7) Regulatory guidance by health agencies in the US, Europe and Canada for MycoVa (H2/2012);
8) Re-launch of new manufactured batch of Totect (H2/2012), partnerships signed for Canadian and European
markets (2012-2013);
9) Initiation of pharmacokinetic bioequivalency trials for PrevOnco in H2/2012;
10) Initiation of clinical trials by partner Exodos for NexACT ibuprofen drug candidate in 2013; and
11) Filing in Europe and other territories for NitroMist, as well as potentially additional partnership activity for
this recently acquired product.
DR D may be unloading some shares but I beleive a filing is required
I actually bought some today at $1.99 as for Slugg he was on margin. too many eggs in one basket.
Nonetheless, don't you feel that we had better communication when Ed Cox was the lone PR guy than now when APRI has or had a PR firm
I am missing Dt D
APRIlov
I have been around a while even before Merlins. So I am not concerned about dig of lack of credibilty.
As for Femprox being a blockbuster, maybe. Great to have it in the pipeline But the PII\II study were done in Chaina in almost 10 years ago. APRI will need another PIII study unless the FDA flip flops like they did with FOLD's drug.
My concern is what other items are in the fire. What about NEAXCT,that is the stuff I was pinning my hopes on.
Dying to see that. My company has hundreds of private label drugs on it shelves and an item with NEXACT technolgy would be great. Not sure why it is not happening
Not basher just bored
Other than EU approval, this company really in a holding pattern. It is really boring. I don't think it is a matter of manipulation, but dead money.
People that play biotechs move in and out. They like action Watch ALXA, ACAD, SCMP, DVAX etc.
But really when is the last time we have had a PR about a new clincial study, progress witht the cancer drugs, etc.
I hope it is as simple as the company is waiting for EU approval and a CN launch, so thaey can get milesotne payments and reinvest in themselves.
The board is not only about due dilligence, it is about debate, conservation, viewpoints etc. MM was constant on the board and that is why he weil be missed.
DG
Is CA where Merlin was from? No Matter
So if he is gone and I hope that is not the case, we need a Moderator
You would be a good one. Can't have this board become YMB
MM could have ben DR D Why not or maybe ED Cox
I don't know but I think he may be gone for good
That is too bad
Wasn't MM from that area. He is MIA but you neverknow if he will show up again
No doubt DR D had some issues with the Board.
The key issue is ae there any barrier to upcoming catalysts
Maybe the Board didn't like the quality of the deals DR D signed off on ( the $$ were not very big)and the Euro Clock Stop which is paralyzing this company
Who know if there is another Euro Clock Stop.
Sure why not. Cox is PR and communication not Strategy.
Hopefully this is about product strategy, commercialiation and not something sinister.
But with this stock any thing goes
I had visions of $10 + a year from now Now I wonder if $4.5 is possible
This is basically a one product company becaue Femprox is a longs ways off and won't even see the light of day unless Vitaros is a solid seller